North America Cannabis Market: Focus on Application, Derivative, and Region – Estimation & Forecast, 2015-2020

Cannabis is the most widely used of all psychoactive drugs in the market due to its derivative products and their uses, its applications and wide acceptance. Owing to the medicinal and industrial uses of the cannabis plant, cannabis market is growing rapidly. Factors like multi-faceted applications of cannabis, expansion of licensing strategies, and automated irrigation system among others are driving this market towards growth.

SKU: EC005A

Published Year: 2015

REQUEST SAMPLE

Owing to the fragmented supply chain and the presence of black market and perception issues, the cannabis market in North America has been estimated and forecasted strictly for the legal states, both for marijuana and hemp.

The following pointers will encompass the scope of the research study and will lend a better understanding to the reader.

• The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp

• The market estimation for marijuana includes revenue from the legalized and active markets and Canada, where only medical marijuana is legalized

• Certain states have legalized medical and recreational marijuana after 2013, however, there markets are not yet active and therefore, their market shares are not included in the total market size for the benchmark year (2014)

• The report includes revenue for the marijuana market for all the active states having market share of above 0.5%. Rest of the state’s revenue are clubbed as others

• Through the forecast period, the ‘other’ states segment will also include the revenue from further states that are anticipated to legalize medical marijuana

• The market size by application has been further segmented as applications of marijuana and industrial hemp for better clarity

• The report includes the estimates of different entities of the cannabis ecosystem

• The report also includes the optimistic revenue estimate for the benchmark year only for the U.S

• Tax revenue estimate in case when marijuana is legalized across all the states in the U.S. has also been included

The size of the market for cannabis implies that market participants are more varied. Thus, the company profile section has been broken down into different types of market participants: producers, information technology, funding & finance, equipment & infrastructure, research & development, advisory services & education, branding, sales & marketing, and retail & dispensary.

REQUEST SAMPLE

TABLE OF CONTENT
1	RESEARCH METHODOLOLOGY, SCOPE AND COVERAGE
1.1	Scope Of The Study
1.2	Research Methodology
1.2.1	Overall Market Estimation And Forecast
1.2.2	Bis Research Methodology
1.3	Report Description
2	EXECUTIVE SUMMARY
3	INTRODUCTION TO NORTH AMERICAN CANNABIS MARKET
3.1	Cannabis Market Evolution And Trend
3.2	The Cannabis Ecosystem In North America: Estimate And Forecast
3.3	The Optimistic Estimate For The U.S. Mrijuana Market
3.4	Tax Revenue Estimation For The U.S. Marijuana Market
4	KEY STRATEGIES AND DEVELOPMENT IN THE NORTH AMERICAN CANNABIS MARKET (2013-2015)
4.1	Introduction
4.2	Mergers And Acquisitions
4.3	Partnership, Collaboration & Joint Ventures
4.4	Product Launch
4.5	Business Expansion
4.6	Product Testing
4.7	Others
5	MARKET DYNAMICS
5.1	Introduction
5.2	Market Drivers
5.2.1	Automation Transforming The Cannabis Industry
5.2.1.1	Collaboration Of The Vending And Cannabis Industry
5.2.1.2	Automated Irrigation Systems And Fertigation
5.2.2	Increasing Adoption Of Information Technology In The Cannabis Industry
5.2.3	Rapid Adoption Of Cannabis For Medical Purposes
5.2.4	Multi-Faceted Applications Of Cannabis Derivatives
5.2.5	The Profitable Integration Of The Hydroponics And Cannabis Industry
5.2.6	The Combined Effect Of Vaper's Preference For Cannabis Oil And Increasing Adoption Of E-Cigarette
5.3	Market Challenges
5.3.1	Highly Volatile Regulatory Framework
5.3.2	Absence Of Market Leaders And Standards
5.3.3	The Issues Of Perception (Reputation Of Marijuana)/Marijuana Stigma
5.3.4	Federal Level Challenges
5.3.4.1	Lack Of Availability Of Bank Loans To Set Up Operations Due To Federal Banking Prerequisites
5.3.4.2	Federal Ban On Growing Industrial Hemp Forcing The Market Players To Import Raw Hemp
5.3.5	Highly Fragmented Supply Chain
5.3.6	Environmental Hazards
6	NORTH AMERICA CANNABIS INDUSTRY ANALYSIS
6.1	Porter’s Five Forces Analysis
6.1.1	Threat Of New Entrants
6.1.1.1	Entry Barriers (Government Policy And Capital Requirements)
6.1.1.2	Access To Distribution Channels
6.1.1.3	Economies Of Scale
6.1.1.4	Product Differentiation
6.1.2	Bargaining Power Of Buyers
6.1.2.1	Concentration Of Buyers
6.1.2.2	Importance Of Volume To Buyers
6.1.2.3	Threat Of Backward Integration
6.1.2.4	Buyer’s Information About Supplier’s Product
6.1.2.5	The Existence Of Black Market
6.1.2.6	Switching Cost
6.1.2.7	Legal And Regulatory Framework
6.1.2.8	Presence Of Substitutes
6.1.3	Bargaining Power Of Suppliers
6.1.3.1	Supplier Concentration
6.1.3.2	Threat Of Forward Integration
6.1.3.3	Product Differentiation
6.1.3.4	Switching Cost
6.1.4	Threat from substitutes
6.1.4.1	Buyer’s Propensity Towards Substitute
6.1.4.2	Consumer’s Switching Cost
6.1.5	Intensity Of Competitive Rivalry
6.1.5.1	Customer’s Loyalty Towards Brand
6.1.5.2	Intermittent Over Capacity
6.1.5.3	Product Differentiation
6.1.5.4	Industry Concentration
6.1.5.5	Entry Barriers
6.1.5.6	Exit Barriers
6.2	Value Chain Analysis
6.2.1	Introduction
6.2.2	Cannabis Growers/Producers
6.2.3	Pharmaceutical Companies
6.2.3.1	Research Facilities
6.2.4	Processing Industries
6.2.5	Packaging Industries
6.2.6	Dispensaries
6.2.6.1	Retail
6.2.6.2	Medical
6.2.6.3	Retail Outlets
7	REGULATORY & LEGAL FRAMEWORK, CONSORTIUMS AND COMPLIANCES
7.1	Introduction
7.2	Regulatory Bodies
7.2.1	Health Canada- Marijuana For Medical Purposes Regulations (MMPR)
7.2.2	Council On Responsible Cannabis Regulation (CRCR)
7.2.3	National Organization For The Reform Of Marijuana Laws (NORML)
7.3	Legal Framework
7.3.1	Federal Marijuana Law- Controlled Substance Act (CSA)
7.3.2	Marijuana Control Act 2014
7.3.3	Hemp Farming Act 2015
7.4	Compliances
7.4.1	Massachusetts Marijuana Compliance
7.4.2	Marijuana Enforcement Tracking Reporting Compliance (METRC)
7.5	Consortiums
7.5.1	American Herbal Products Association (AHPA)
7.5.2	Association Of Responsible Cannabis Public Companies (ARCPC)
7.5.3	Hemp Industries Association (HIA)
7.5.4	Drug Policy Alliance
7.5.5	International Association For Cannabinoid Medicine (IACM)
7.5.6	National Cannabis Industry Association (NCIA)
7.5.7	Canadian Medical Cannabis Industry Association (CMCIA)
7.5.8	California Cannabis Industry Association (CCIA)
7.5.9	Illinois Cannabis Industry Association
7.5.10	North American Industrial Hemp Council Inc. (NAIHC)
7.5.11	Canadian Hemp Trade Alliance (CHTA)
7.5.12	Kentucky Hemp Industries Association(KYHIA)
8	MARKET SIZING – ESTIMATION, ANALYSIS & FORECAST BY DERIVATIVE
8.1	Introduction
8.1.1	Market Statistics
8.1.2	Marijuana/Flowers
8.1.2.1	Market Statistics
8.1.2.2	Key Players
8.1.3	Industrial Hemp
8.1.3.1	Market Statistics
8.1.3.2	Key Players
8.1.4	Other Concentrates/Products
8.1.4.1	Kief
8.1.4.2	Hash
8.1.4.3	Hash Oil
8.1.4.4	Tinctures
8.1.4.5	Infusions
9	MARKET SIZING- ESTIMATION, ANALYSIS & FORECAST BY APPLICATION
9.1	Introduction
9.1.1	Market Statistics
9.2	Applications Of Marijuana
9.2.1	Medicinal Applications
9.2.1.1	Market Statistics
9.2.1.2	Key Players
9.2.2	Recreational Application Of Marijuana
9.2.2.1	Market Statistics
9.3	Applications Of Industrial Hemp
9.3.1	Food And Baby Care
9.3.1.1	Market Statistics
9.3.2	Clothing & Textile
9.3.2.1	Market Statistics
9.3.3	Other Hemp Products
9.3.3.1	Market Statistics
10	MARKET SIZING ANALYSIS & FORECAST, BY MARKET DEMAND
10.1	Introduction
10.1.1	Market Statistics
10.2	The U.S.
10.2.1	Market Statistics
10.2.2	California
10.2.3	Colorado
10.2.4	Washington
10.2.5	Arizona
10.2.6	Michigan
10.2.7	Oregon
10.2.8	Others
10.2.9	Legal & Regulatory Framework
10.2.9.1	Marijuana
10.2.9.2	Industrial Hemp
10.2.10	Key Market Players
10.3	Canada
10.3.1	Market Statistics
10.3.2	Key Market Players
11	KEY MARKET PLAYERS PROFILE
11.1	Growers
11.1.1	Canadian Cannabis Corporation
11.1.1.1	Company Overview
11.1.1.2	Financials
11.1.1.2.1	Overall Financials
11.1.1.2.2	Financial Summary
11.1.1.3	Key Developments
11.1.2	Plandai Biotechnology
11.1.2.1	Company Overview
11.1.2.2	Financials
11.1.2.2.1	Overall Financials
11.1.2.2.2	Financial Summary
11.1.2.3	Key Developments
11.1.3	Tweed Marijuana Inc.
11.1.3.1	Company Overview
11.1.3.2	Financials
11.1.3.2.1	Overall Financials
11.1.3.2.2	Financial Summary
11.1.3.3	Key Developments
11.1.4	Affinor Growers
11.1.4.1	Company Overview
11.1.4.2	Financials
11.1.4.2.1	Overall Financials
11.1.4.2.2	Financial Summary
11.1.4.3	Key Developments
11.2	Producers
11.2.1	Cannabis Sativa Inc.
11.2.1.1	Company Overview
11.2.1.2	Financials
11.2.1.2.1	Overall Financials
11.2.1.2.2	Financial Summary
11.2.1.3	Key Developments
11.2.2	Cannavest
11.2.2.1	Company Overview
11.2.2.2	Financials
11.2.2.2.1	Overall Financials
11.2.2.2.2	Financial Summary
11.2.2.3	Key Developments
11.2.3	Canna Brands Inc.
11.2.3.1	Company Overview
11.2.3.2	Financial Summary
11.2.3.3	Key Developments
11.2.4	Omnicanna Health Solutions
11.2.4.1	Company Overview
11.2.4.2	Financial Summary
11.2.4.3	Key Developments
11.2.5	Privateer Holdings, Inc.
11.2.5.1	Company Overview
11.2.5.2	Key Developments
11.3	Pharmaceutical & Research Companies
11.3.1	Arena Pharmaceuticals, Inc.
11.3.1.1	Company Overview
11.3.1.2	Financials
11.3.1.2.1	Overall Financials
11.3.1.2.2	Financial Summary
11.3.1.3	Key Developments
11.3.2	Cannabics Pharmaceuticals Inc.
11.3.2.1	Company Overview
11.3.2.2	Financial Summary
11.3.2.3	Key Developments
11.3.3	Cannabis Science, Inc.
11.3.3.1	Company Overview
11.3.3.2	Financials
11.3.3.2.1	Overall Financials
11.3.3.2.2	Financial Summary
11.3.3.3	Key Developments
11.3.4	GW Pharmaceuticals
11.3.4.1	Company Overview
11.3.4.2	Financials
11.3.4.2.1	Overall Financials
11.3.4.2.2	Revenue By Segment
11.3.4.2.3	Revenue By Region
11.3.4.2.4	Financial Summary
11.3.4.3	Key Developments
11.3.5	Hemp, Inc.
11.3.5.1	Company Overview
11.3.5.2	Financials
11.3.5.2.1	Overall Financials
11.3.5.2.2	Financial Summary
11.3.5.3	Key Developments
11.3.6	Insys Therapeutics
11.3.6.1	Company Overview
11.3.6.2	Financials
11.3.6.2.1	Overall Financials
11.3.6.2.2	Revenue By Segment
11.3.6.2.3	Financial Summary
11.3.6.3	Key Developments
11.3.7	Medical Marijuana Inc.
11.3.7.1	Company Overview
11.3.7.2	Financials
11.3.7.2.1	Overall Financials
11.3.7.2.2	Financial Summary
11.3.7.3	Key Developments
11.3.8	22nd Century Group, Inc.
11.3.8.1	Company Overview
11.3.8.2	Financials
11.3.8.2.1	Overall Financials
11.3.8.2.2	Financial Summary
11.3.8.3	Key Developments
11.3.9	Otsuka Pharmaceutical Co. Ltd
11.3.9.1	Company Overview
11.3.9.2	Financials
11.3.9.2.1	Overall Financials
11.3.9.2.2	Revenue By Segment
11.3.9.2.3	Revenue By Region
11.3.9.2.4	Financial Summary
11.3.9.3	Key Developments
11.3.10	Sanofi Pharmaceuticals
11.3.10.1	Company Overview
11.3.10.2	Financials
11.3.10.2.1	Overall Financials
11.3.10.2.2	Financial Summary
11.4	Information Technology
11.4.1	Agrisoft Development Group
11.4.1.1	Company Overview
11.4.1.2	Key Developments
11.4.2	Endexx Corporation
11.4.2.1	Company Overview
11.4.2.2	Financials
11.4.2.2.1	Overall Financials
11.4.2.3	Key Developments
11.4.3	Green Technology Solutions Inc. (GTSO)
11.4.3.1	Company Overview
11.4.3.2	Financials
11.4.3.2.1	Overall Financials
11.4.3.2.2	Financial Summary
11.4.3.3	Key Developments
11.4.4	Quantum 9
11.4.4.1	Company Overview
11.4.4.2	Financials
11.4.4.3	Key Developments
11.5	Equipment & Infrastructure
11.5.1	Advanced Cannabis Solutions
11.5.1.1	Company Overview
11.5.1.2	Financials
11.5.1.2.1	Overall Financials
11.5.1.2.2	Revenue By Segment
11.5.1.2.3	Financial Summary
11.5.1.3	Key Developments
11.5.2	Medbox, Inc.
11.5.2.1	Company Overview
11.5.2.2	Financials
11.5.2.2.1	Overall financials
11.5.2.2.2	Financial Summary
11.5.2.3	Key Developments
11.5.3	Surna, Inc.
11.5.3.1	Company Overview
11.5.3.2	Financials
11.5.3.2.1	Overall Financials
11.5.3.2.2	Financial Summary
11.5.3.3	Key Developments
11.6	Advisory Services And Education
11.6.1	Canna Grow Holdings
11.6.1.1	Company Overview
11.6.1.2	Financials
11.6.1.2.1	Overall Financials
11.6.1.2.2	Financial Summary
11.6.1.3	Key Developments
11.7	Others
11.7.1	Abattis Bioceuticals Corporation
11.7.1.1	Company Overview
11.7.1.2	Financials
11.7.1.2.1	Overall Financials
11.7.1.2.2	Financial Summary
11.7.1.3	Key Developments
11.7.2	Cannabis Therapy Corporation
11.7.2.1	Company Overview
11.7.2.2	Financials
11.7.2.2.1	Overall Financials
11.7.2.2.2	Financial Summary
11.7.2.3	Key Developments
11.7.3	Cannacare Docs
11.7.3.1	Company Overview
11.8	Application (APPS) Companies
11.8.1	Mass Roots
11.8.1.1	Company Overview
11.8.2	Eaze
11.8.2.1	Company Overview
11.8.2.2	Key Developments
11.8.3	Weedmaps
11.8.3.1	Company Overview
11.8.4	Meadow
11.8.4.1	Company Overview
11.8.4.2	Key Developments
11.8.5	Nestdrop
11.8.5.1	Company Overview
11.8.5.2	Key Developments
11.8.6	Leafly
11.8.6.1	Company Overview
11.8.7	Grassp
11.8.7.1	Company Overview
11.8.8	Dave
11.8.8.1	Company Overview
11.8.9	Frweed Pro
11.8.9.1	Company Overview
LIST OF TABLES
TABLE 1	TIMELINE OF MEDICAL MARIJUANA LEGALIZATION
TABLE 2	THE CANNABIS ECOSYSTEM IN NORTH AMERICA REVENUE SPLIT ($BILLION), 2015-2020
TABLE 3	FULL LEGALIZATION OF MARIJUANA ACROSS THE U.S. AND ASSOCIATED TAX REVENUE ESTIMATE
TABLE 4	COMPARISON OF GROWING MARIJUANA IN SOIL-BASED AND SOIL-LESS MEDIUM
TABLE 5	CANNABIS SATIVA VS CANNABIS INDICA
TABLE 6	NORTH AMERICA CANNABIS DERIVATIVE MARKET VALUE ($MILLION), 2015-2020
TABLE 7	NORTH AMERICA MARIJUANA MARKET VALUE($MILLION), BY APPLICATION, 2015-2020
TABLE 8	NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE, 2015-2020
TABLE 9	NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 10	NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020
TABLE 11	NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY DISTRIBUTIONMODE, 2015-2020
TABLE 12	NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($ MILLION), BY GEOGRAPHY, 2015-2020
TABLE 13	NORTH AMERICA CANNABIS APPLICATION MARKET VALUE ($MILLION), 2015-2020
TABLE 14	DISEASES & CURE BY CANNABIS
TABLE 15	INFORMATION ABOUT KEY MEDICINAL MARIJUANA DRUGS IN NORTH AMERICA
TABLE 16	NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE, 2015-2020
TABLE 17	NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 18	NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 19	NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 20	NORTH AMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 21	NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATION MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 22	NORTH AMERICA CANNABIS MARKET BY REGION ($ MILLION), 2015-2020
TABLE 23	THE U.S CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020
TABLE 24	THE U.S. CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020
TABLE 25	THE U.S. MARIJUANA MARKET VALUE ($MILLION), BY KEY STATES, 2015-2020
TABLE 26	MARIJUANA LEGALIZATION DETAILS BY STATES
TABLE 27	MARIJUANA POSESSION DETAILS
TABLE 28	INDUSTRIAL HEMP POSESSION DETAILS
TABLE 29	CANADA CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020
TABLE 30	CANADA CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020
LIST OF FIGURES
FIGURE 1	BIS RESEARCH METHODOLOGY
FIGURE 2	THE EUROPE E-LIQUID MARKET-RESEARCH METHODOLOGY
FIGURE 3	CANNABIS COMPARISON BY DERIVATIVE ($MILLION) 2015-2020
FIGURE 4	CANNABIS COMPARISON BY APPLICATION ($ MILLION) 2014-2020
FIGURE 5	CANNABIS COMPARISON BY GEOGRAPHY ($ MILLION) 2014-2020
FIGURE 6	THE CANNABIS ECOSYSTEM WITH KEY PLAYERS
FIGURE 7	AN OPTIMISTIC ESTIMATE FOR U.S. MARIJUANA MARKET (2014)
FIGURE 8	KEY MERGERS & ACQUISITIONS (2013-15)
FIGURE 9	KEY PARTNERSHIPS & COLLABORATIONS (2013-15)
FIGURE 10	KEY PRODUCT LAUNCHES (2013-15)
FIGURE 11	KEY BUSINESS EXPANSION ACTIVITIES (2013-15)
FIGURE 12	KEY PRODUCT TESTING ACTIVITIES (2013-15)
FIGURE 13	OTHER KEY DEVELOPMENTS (2013-15)
FIGURE 14	BENEFITS OF USING CANNABIS VENDING MACHINES
FIGURE 15	WHY CANNABIS INDUSTRY NEEDS STANDARDS
FIGURE 16	NORTH AMERICA CANNABIS INDUSTRY ANALYSIS-PORTER’S FIVE FORCES
FIGURE 17	NORTH AMERICA CANNABIS MARKET VALUE CHAIN ANALYSIS
FIGURE 18	FEATURE OF MMPR
FIGURE 19	MISSION OF CRCR
FIGURE 20	MISSION OF NORML
FIGURE 21	PROPOSED BEST PRACTICES FOR REGULATION OF CANNABIS GROWING BY AHPA
FIGURE 22	ARCPC MISSION
FIGURE 23	HIA MISSION
FIGURE 24	DPA MISSION
FIGURE 25	STEPS TAKEN BY IACM IN THE CANNABIS INDUSTRY
FIGURE 26	KEY FEATURES OF NCIA
FIGURE 27	CMCIA MISSION
FIGURE 28	NAIHC MISSION
FIGURE 29	KEY VARIETIES OF CANNABIS STRAINS
FIGURE 30	THE PSYCHOACTIVE EFFECTS OF MARIJUANA
FIGURE 31	MEDICAL BENEFITS OF MARIJUANA
FIGURE 32	INDUSTRIES BENEFITING FROM INDUSTRIAL HEMP
FIGURE 33	APPLICATIONS OF CANNABIS PLANT
FIGURE 34	NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 35	NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 36	APPLICATIONS OF INDUSTRIAL HEMP
FIGURE 37	NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 38	NORTHAMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 39	NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATIONS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 40	LEGALIZATION STATUS OF CANNABIS
FIGURE 41	CANADIAN CANNABIS CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 42	PLANDAI BIOTECH OVERALL FINANCIALS, 2012-15 ($ MILLION)
FIGURE 43	TWEED MARIJUANA OVERALL FINANCIALS, 2013-15 ($ MILLION)
FIGURE 44	AFFINOR GROWERS OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 45	CANNABIS SATIVA OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 46	CANNAVEST OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 47	ARENA PHARMACEUTICALS OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 48	CANNABIS SCIENCE, INC. OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 49	GW PHARMACEUTICALS; OVERALL FINANCIALS 2012-14 ($MILLION)
FIGURE 50	REVENUE BY SEGMENT 2012-14
FIGURE 51	REVENUE BY REGION2012-2014
FIGURE 52	HEMP INC. OVERALL FINANCIALS, 2012-15 ($ MILLION)
FIGURE 53	INSYS THERAPEUTICS OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 54	MEDICAL MARIJUANA INC. OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 55	22ND CENTURY GROUP OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 56	OTSUKA OVERALL FINANCIALS, 2012-2014 ($ MILLION)
FIGURE 57	SANOFIPHARMA OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 58	ENDEXX CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 59	GREEN TECHNOLOGY SOLUTIONS; OVERALL FINANCIALS, 2012-2015 ($ MILLION)
FIGURE 60	ADVANCED CANNABIS SOLUTIONS OVERALL FINANCIALS, 2013-2014 ($ MILLION)
FIGURE 61	MEDBOX OVERALL FINANCIALS, 2012-2014 ($ MILLION)
FIGURE 62	SURNA INC. OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 63	CANNAGROW OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 64	ABATTIS BIOCEUTICALS OVERALL FINANCIALS 2013-14 ($MILLION)
FIGURE 65	CANNABIS THERAPY CORP. OVERALL FINANCIALS, 2014-15 ($MILLION)

REQUEST SAMPLE

The U.S. state California generates the maximum revenue $1.15 billion in the marijuana market among all the states in the U.S. while Oregon and Rhode Island will be growing at the fastest CAGR of 36.10% and 36.93% respectively. If the industry keeps on growing with the same pace, it will spread to all the 50 states of the U.S.

REQUEST SAMPLE

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information

REQUEST SAMPLE

REQUEST SAMPLE

TABLE OF CONTENT
1	RESEARCH METHODOLOLOGY, SCOPE AND COVERAGE
1.1	Scope Of The Study
1.2	Research Methodology
1.2.1	Overall Market Estimation And Forecast
1.2.2	Bis Research Methodology
1.3	Report Description
2	EXECUTIVE SUMMARY
3	INTRODUCTION TO NORTH AMERICAN CANNABIS MARKET
3.1	Cannabis Market Evolution And Trend
3.2	The Cannabis Ecosystem In North America: Estimate And Forecast
3.3	The Optimistic Estimate For The U.S. Mrijuana Market
3.4	Tax Revenue Estimation For The U.S. Marijuana Market
4	KEY STRATEGIES AND DEVELOPMENT IN THE NORTH AMERICAN CANNABIS MARKET (2013-2015)
4.1	Introduction
4.2	Mergers And Acquisitions
4.3	Partnership, Collaboration & Joint Ventures
4.4	Product Launch
4.5	Business Expansion
4.6	Product Testing
4.7	Others
5	MARKET DYNAMICS
5.1	Introduction
5.2	Market Drivers
5.2.1	Automation Transforming The Cannabis Industry
5.2.1.1	Collaboration Of The Vending And Cannabis Industry
5.2.1.2	Automated Irrigation Systems And Fertigation
5.2.2	Increasing Adoption Of Information Technology In The Cannabis Industry
5.2.3	Rapid Adoption Of Cannabis For Medical Purposes
5.2.4	Multi-Faceted Applications Of Cannabis Derivatives
5.2.5	The Profitable Integration Of The Hydroponics And Cannabis Industry
5.2.6	The Combined Effect Of Vaper's Preference For Cannabis Oil And Increasing Adoption Of E-Cigarette
5.3	Market Challenges
5.3.1	Highly Volatile Regulatory Framework
5.3.2	Absence Of Market Leaders And Standards
5.3.3	The Issues Of Perception (Reputation Of Marijuana)/Marijuana Stigma
5.3.4	Federal Level Challenges
5.3.4.1	Lack Of Availability Of Bank Loans To Set Up Operations Due To Federal Banking Prerequisites
5.3.4.2	Federal Ban On Growing Industrial Hemp Forcing The Market Players To Import Raw Hemp
5.3.5	Highly Fragmented Supply Chain
5.3.6	Environmental Hazards
6	NORTH AMERICA CANNABIS INDUSTRY ANALYSIS
6.1	Porter’s Five Forces Analysis
6.1.1	Threat Of New Entrants
6.1.1.1	Entry Barriers (Government Policy And Capital Requirements)
6.1.1.2	Access To Distribution Channels
6.1.1.3	Economies Of Scale
6.1.1.4	Product Differentiation
6.1.2	Bargaining Power Of Buyers
6.1.2.1	Concentration Of Buyers
6.1.2.2	Importance Of Volume To Buyers
6.1.2.3	Threat Of Backward Integration
6.1.2.4	Buyer’s Information About Supplier’s Product
6.1.2.5	The Existence Of Black Market
6.1.2.6	Switching Cost
6.1.2.7	Legal And Regulatory Framework
6.1.2.8	Presence Of Substitutes
6.1.3	Bargaining Power Of Suppliers
6.1.3.1	Supplier Concentration
6.1.3.2	Threat Of Forward Integration
6.1.3.3	Product Differentiation
6.1.3.4	Switching Cost
6.1.4	Threat from substitutes
6.1.4.1	Buyer’s Propensity Towards Substitute
6.1.4.2	Consumer’s Switching Cost
6.1.5	Intensity Of Competitive Rivalry
6.1.5.1	Customer’s Loyalty Towards Brand
6.1.5.2	Intermittent Over Capacity
6.1.5.3	Product Differentiation
6.1.5.4	Industry Concentration
6.1.5.5	Entry Barriers
6.1.5.6	Exit Barriers
6.2	Value Chain Analysis
6.2.1	Introduction
6.2.2	Cannabis Growers/Producers
6.2.3	Pharmaceutical Companies
6.2.3.1	Research Facilities
6.2.4	Processing Industries
6.2.5	Packaging Industries
6.2.6	Dispensaries
6.2.6.1	Retail
6.2.6.2	Medical
6.2.6.3	Retail Outlets
7	REGULATORY & LEGAL FRAMEWORK, CONSORTIUMS AND COMPLIANCES
7.1	Introduction
7.2	Regulatory Bodies
7.2.1	Health Canada- Marijuana For Medical Purposes Regulations (MMPR)
7.2.2	Council On Responsible Cannabis Regulation (CRCR)
7.2.3	National Organization For The Reform Of Marijuana Laws (NORML)
7.3	Legal Framework
7.3.1	Federal Marijuana Law- Controlled Substance Act (CSA)
7.3.2	Marijuana Control Act 2014
7.3.3	Hemp Farming Act 2015
7.4	Compliances
7.4.1	Massachusetts Marijuana Compliance
7.4.2	Marijuana Enforcement Tracking Reporting Compliance (METRC)
7.5	Consortiums
7.5.1	American Herbal Products Association (AHPA)
7.5.2	Association Of Responsible Cannabis Public Companies (ARCPC)
7.5.3	Hemp Industries Association (HIA)
7.5.4	Drug Policy Alliance
7.5.5	International Association For Cannabinoid Medicine (IACM)
7.5.6	National Cannabis Industry Association (NCIA)
7.5.7	Canadian Medical Cannabis Industry Association (CMCIA)
7.5.8	California Cannabis Industry Association (CCIA)
7.5.9	Illinois Cannabis Industry Association
7.5.10	North American Industrial Hemp Council Inc. (NAIHC)
7.5.11	Canadian Hemp Trade Alliance (CHTA)
7.5.12	Kentucky Hemp Industries Association(KYHIA)
8	MARKET SIZING – ESTIMATION, ANALYSIS & FORECAST BY DERIVATIVE
8.1	Introduction
8.1.1	Market Statistics
8.1.2	Marijuana/Flowers
8.1.2.1	Market Statistics
8.1.2.2	Key Players
8.1.3	Industrial Hemp
8.1.3.1	Market Statistics
8.1.3.2	Key Players
8.1.4	Other Concentrates/Products
8.1.4.1	Kief
8.1.4.2	Hash
8.1.4.3	Hash Oil
8.1.4.4	Tinctures
8.1.4.5	Infusions
9	MARKET SIZING- ESTIMATION, ANALYSIS & FORECAST BY APPLICATION
9.1	Introduction
9.1.1	Market Statistics
9.2	Applications Of Marijuana
9.2.1	Medicinal Applications
9.2.1.1	Market Statistics
9.2.1.2	Key Players
9.2.2	Recreational Application Of Marijuana
9.2.2.1	Market Statistics
9.3	Applications Of Industrial Hemp
9.3.1	Food And Baby Care
9.3.1.1	Market Statistics
9.3.2	Clothing & Textile
9.3.2.1	Market Statistics
9.3.3	Other Hemp Products
9.3.3.1	Market Statistics
10	MARKET SIZING ANALYSIS & FORECAST, BY MARKET DEMAND
10.1	Introduction
10.1.1	Market Statistics
10.2	The U.S.
10.2.1	Market Statistics
10.2.2	California
10.2.3	Colorado
10.2.4	Washington
10.2.5	Arizona
10.2.6	Michigan
10.2.7	Oregon
10.2.8	Others
10.2.9	Legal & Regulatory Framework
10.2.9.1	Marijuana
10.2.9.2	Industrial Hemp
10.2.10	Key Market Players
10.3	Canada
10.3.1	Market Statistics
10.3.2	Key Market Players
11	KEY MARKET PLAYERS PROFILE
11.1	Growers
11.1.1	Canadian Cannabis Corporation
11.1.1.1	Company Overview
11.1.1.2	Financials
11.1.1.2.1	Overall Financials
11.1.1.2.2	Financial Summary
11.1.1.3	Key Developments
11.1.2	Plandai Biotechnology
11.1.2.1	Company Overview
11.1.2.2	Financials
11.1.2.2.1	Overall Financials
11.1.2.2.2	Financial Summary
11.1.2.3	Key Developments
11.1.3	Tweed Marijuana Inc.
11.1.3.1	Company Overview
11.1.3.2	Financials
11.1.3.2.1	Overall Financials
11.1.3.2.2	Financial Summary
11.1.3.3	Key Developments
11.1.4	Affinor Growers
11.1.4.1	Company Overview
11.1.4.2	Financials
11.1.4.2.1	Overall Financials
11.1.4.2.2	Financial Summary
11.1.4.3	Key Developments
11.2	Producers
11.2.1	Cannabis Sativa Inc.
11.2.1.1	Company Overview
11.2.1.2	Financials
11.2.1.2.1	Overall Financials
11.2.1.2.2	Financial Summary
11.2.1.3	Key Developments
11.2.2	Cannavest
11.2.2.1	Company Overview
11.2.2.2	Financials
11.2.2.2.1	Overall Financials
11.2.2.2.2	Financial Summary
11.2.2.3	Key Developments
11.2.3	Canna Brands Inc.
11.2.3.1	Company Overview
11.2.3.2	Financial Summary
11.2.3.3	Key Developments
11.2.4	Omnicanna Health Solutions
11.2.4.1	Company Overview
11.2.4.2	Financial Summary
11.2.4.3	Key Developments
11.2.5	Privateer Holdings, Inc.
11.2.5.1	Company Overview
11.2.5.2	Key Developments
11.3	Pharmaceutical & Research Companies
11.3.1	Arena Pharmaceuticals, Inc.
11.3.1.1	Company Overview
11.3.1.2	Financials
11.3.1.2.1	Overall Financials
11.3.1.2.2	Financial Summary
11.3.1.3	Key Developments
11.3.2	Cannabics Pharmaceuticals Inc.
11.3.2.1	Company Overview
11.3.2.2	Financial Summary
11.3.2.3	Key Developments
11.3.3	Cannabis Science, Inc.
11.3.3.1	Company Overview
11.3.3.2	Financials
11.3.3.2.1	Overall Financials
11.3.3.2.2	Financial Summary
11.3.3.3	Key Developments
11.3.4	GW Pharmaceuticals
11.3.4.1	Company Overview
11.3.4.2	Financials
11.3.4.2.1	Overall Financials
11.3.4.2.2	Revenue By Segment
11.3.4.2.3	Revenue By Region
11.3.4.2.4	Financial Summary
11.3.4.3	Key Developments
11.3.5	Hemp, Inc.
11.3.5.1	Company Overview
11.3.5.2	Financials
11.3.5.2.1	Overall Financials
11.3.5.2.2	Financial Summary
11.3.5.3	Key Developments
11.3.6	Insys Therapeutics
11.3.6.1	Company Overview
11.3.6.2	Financials
11.3.6.2.1	Overall Financials
11.3.6.2.2	Revenue By Segment
11.3.6.2.3	Financial Summary
11.3.6.3	Key Developments
11.3.7	Medical Marijuana Inc.
11.3.7.1	Company Overview
11.3.7.2	Financials
11.3.7.2.1	Overall Financials
11.3.7.2.2	Financial Summary
11.3.7.3	Key Developments
11.3.8	22nd Century Group, Inc.
11.3.8.1	Company Overview
11.3.8.2	Financials
11.3.8.2.1	Overall Financials
11.3.8.2.2	Financial Summary
11.3.8.3	Key Developments
11.3.9	Otsuka Pharmaceutical Co. Ltd
11.3.9.1	Company Overview
11.3.9.2	Financials
11.3.9.2.1	Overall Financials
11.3.9.2.2	Revenue By Segment
11.3.9.2.3	Revenue By Region
11.3.9.2.4	Financial Summary
11.3.9.3	Key Developments
11.3.10	Sanofi Pharmaceuticals
11.3.10.1	Company Overview
11.3.10.2	Financials
11.3.10.2.1	Overall Financials
11.3.10.2.2	Financial Summary
11.4	Information Technology
11.4.1	Agrisoft Development Group
11.4.1.1	Company Overview
11.4.1.2	Key Developments
11.4.2	Endexx Corporation
11.4.2.1	Company Overview
11.4.2.2	Financials
11.4.2.2.1	Overall Financials
11.4.2.3	Key Developments
11.4.3	Green Technology Solutions Inc. (GTSO)
11.4.3.1	Company Overview
11.4.3.2	Financials
11.4.3.2.1	Overall Financials
11.4.3.2.2	Financial Summary
11.4.3.3	Key Developments
11.4.4	Quantum 9
11.4.4.1	Company Overview
11.4.4.2	Financials
11.4.4.3	Key Developments
11.5	Equipment & Infrastructure
11.5.1	Advanced Cannabis Solutions
11.5.1.1	Company Overview
11.5.1.2	Financials
11.5.1.2.1	Overall Financials
11.5.1.2.2	Revenue By Segment
11.5.1.2.3	Financial Summary
11.5.1.3	Key Developments
11.5.2	Medbox, Inc.
11.5.2.1	Company Overview
11.5.2.2	Financials
11.5.2.2.1	Overall financials
11.5.2.2.2	Financial Summary
11.5.2.3	Key Developments
11.5.3	Surna, Inc.
11.5.3.1	Company Overview
11.5.3.2	Financials
11.5.3.2.1	Overall Financials
11.5.3.2.2	Financial Summary
11.5.3.3	Key Developments
11.6	Advisory Services And Education
11.6.1	Canna Grow Holdings
11.6.1.1	Company Overview
11.6.1.2	Financials
11.6.1.2.1	Overall Financials
11.6.1.2.2	Financial Summary
11.6.1.3	Key Developments
11.7	Others
11.7.1	Abattis Bioceuticals Corporation
11.7.1.1	Company Overview
11.7.1.2	Financials
11.7.1.2.1	Overall Financials
11.7.1.2.2	Financial Summary
11.7.1.3	Key Developments
11.7.2	Cannabis Therapy Corporation
11.7.2.1	Company Overview
11.7.2.2	Financials
11.7.2.2.1	Overall Financials
11.7.2.2.2	Financial Summary
11.7.2.3	Key Developments
11.7.3	Cannacare Docs
11.7.3.1	Company Overview
11.8	Application (APPS) Companies
11.8.1	Mass Roots
11.8.1.1	Company Overview
11.8.2	Eaze
11.8.2.1	Company Overview
11.8.2.2	Key Developments
11.8.3	Weedmaps
11.8.3.1	Company Overview
11.8.4	Meadow
11.8.4.1	Company Overview
11.8.4.2	Key Developments
11.8.5	Nestdrop
11.8.5.1	Company Overview
11.8.5.2	Key Developments
11.8.6	Leafly
11.8.6.1	Company Overview
11.8.7	Grassp
11.8.7.1	Company Overview
11.8.8	Dave
11.8.8.1	Company Overview
11.8.9	Frweed Pro
11.8.9.1	Company Overview
LIST OF TABLES
TABLE 1	TIMELINE OF MEDICAL MARIJUANA LEGALIZATION
TABLE 2	THE CANNABIS ECOSYSTEM IN NORTH AMERICA REVENUE SPLIT ($BILLION), 2015-2020
TABLE 3	FULL LEGALIZATION OF MARIJUANA ACROSS THE U.S. AND ASSOCIATED TAX REVENUE ESTIMATE
TABLE 4	COMPARISON OF GROWING MARIJUANA IN SOIL-BASED AND SOIL-LESS MEDIUM
TABLE 5	CANNABIS SATIVA VS CANNABIS INDICA
TABLE 6	NORTH AMERICA CANNABIS DERIVATIVE MARKET VALUE ($MILLION), 2015-2020
TABLE 7	NORTH AMERICA MARIJUANA MARKET VALUE($MILLION), BY APPLICATION, 2015-2020
TABLE 8	NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE, 2015-2020
TABLE 9	NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 10	NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020
TABLE 11	NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY DISTRIBUTIONMODE, 2015-2020
TABLE 12	NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($ MILLION), BY GEOGRAPHY, 2015-2020
TABLE 13	NORTH AMERICA CANNABIS APPLICATION MARKET VALUE ($MILLION), 2015-2020
TABLE 14	DISEASES & CURE BY CANNABIS
TABLE 15	INFORMATION ABOUT KEY MEDICINAL MARIJUANA DRUGS IN NORTH AMERICA
TABLE 16	NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE, 2015-2020
TABLE 17	NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 18	NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 19	NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 20	NORTH AMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 21	NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATION MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 22	NORTH AMERICA CANNABIS MARKET BY REGION ($ MILLION), 2015-2020
TABLE 23	THE U.S CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020
TABLE 24	THE U.S. CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020
TABLE 25	THE U.S. MARIJUANA MARKET VALUE ($MILLION), BY KEY STATES, 2015-2020
TABLE 26	MARIJUANA LEGALIZATION DETAILS BY STATES
TABLE 27	MARIJUANA POSESSION DETAILS
TABLE 28	INDUSTRIAL HEMP POSESSION DETAILS
TABLE 29	CANADA CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020
TABLE 30	CANADA CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020
LIST OF FIGURES
FIGURE 1	BIS RESEARCH METHODOLOGY
FIGURE 2	THE EUROPE E-LIQUID MARKET-RESEARCH METHODOLOGY
FIGURE 3	CANNABIS COMPARISON BY DERIVATIVE ($MILLION) 2015-2020
FIGURE 4	CANNABIS COMPARISON BY APPLICATION ($ MILLION) 2014-2020
FIGURE 5	CANNABIS COMPARISON BY GEOGRAPHY ($ MILLION) 2014-2020
FIGURE 6	THE CANNABIS ECOSYSTEM WITH KEY PLAYERS
FIGURE 7	AN OPTIMISTIC ESTIMATE FOR U.S. MARIJUANA MARKET (2014)
FIGURE 8	KEY MERGERS & ACQUISITIONS (2013-15)
FIGURE 9	KEY PARTNERSHIPS & COLLABORATIONS (2013-15)
FIGURE 10	KEY PRODUCT LAUNCHES (2013-15)
FIGURE 11	KEY BUSINESS EXPANSION ACTIVITIES (2013-15)
FIGURE 12	KEY PRODUCT TESTING ACTIVITIES (2013-15)
FIGURE 13	OTHER KEY DEVELOPMENTS (2013-15)
FIGURE 14	BENEFITS OF USING CANNABIS VENDING MACHINES
FIGURE 15	WHY CANNABIS INDUSTRY NEEDS STANDARDS
FIGURE 16	NORTH AMERICA CANNABIS INDUSTRY ANALYSIS-PORTER’S FIVE FORCES
FIGURE 17	NORTH AMERICA CANNABIS MARKET VALUE CHAIN ANALYSIS
FIGURE 18	FEATURE OF MMPR
FIGURE 19	MISSION OF CRCR
FIGURE 20	MISSION OF NORML
FIGURE 21	PROPOSED BEST PRACTICES FOR REGULATION OF CANNABIS GROWING BY AHPA
FIGURE 22	ARCPC MISSION
FIGURE 23	HIA MISSION
FIGURE 24	DPA MISSION
FIGURE 25	STEPS TAKEN BY IACM IN THE CANNABIS INDUSTRY
FIGURE 26	KEY FEATURES OF NCIA
FIGURE 27	CMCIA MISSION
FIGURE 28	NAIHC MISSION
FIGURE 29	KEY VARIETIES OF CANNABIS STRAINS
FIGURE 30	THE PSYCHOACTIVE EFFECTS OF MARIJUANA
FIGURE 31	MEDICAL BENEFITS OF MARIJUANA
FIGURE 32	INDUSTRIES BENEFITING FROM INDUSTRIAL HEMP
FIGURE 33	APPLICATIONS OF CANNABIS PLANT
FIGURE 34	NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 35	NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 36	APPLICATIONS OF INDUSTRIAL HEMP
FIGURE 37	NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 38	NORTHAMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 39	NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATIONS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 40	LEGALIZATION STATUS OF CANNABIS
FIGURE 41	CANADIAN CANNABIS CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 42	PLANDAI BIOTECH OVERALL FINANCIALS, 2012-15 ($ MILLION)
FIGURE 43	TWEED MARIJUANA OVERALL FINANCIALS, 2013-15 ($ MILLION)
FIGURE 44	AFFINOR GROWERS OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 45	CANNABIS SATIVA OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 46	CANNAVEST OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 47	ARENA PHARMACEUTICALS OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 48	CANNABIS SCIENCE, INC. OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 49	GW PHARMACEUTICALS; OVERALL FINANCIALS 2012-14 ($MILLION)
FIGURE 50	REVENUE BY SEGMENT 2012-14
FIGURE 51	REVENUE BY REGION2012-2014
FIGURE 52	HEMP INC. OVERALL FINANCIALS, 2012-15 ($ MILLION)
FIGURE 53	INSYS THERAPEUTICS OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 54	MEDICAL MARIJUANA INC. OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 55	22ND CENTURY GROUP OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 56	OTSUKA OVERALL FINANCIALS, 2012-2014 ($ MILLION)
FIGURE 57	SANOFIPHARMA OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 58	ENDEXX CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 59	GREEN TECHNOLOGY SOLUTIONS; OVERALL FINANCIALS, 2012-2015 ($ MILLION)
FIGURE 60	ADVANCED CANNABIS SOLUTIONS OVERALL FINANCIALS, 2013-2014 ($ MILLION)
FIGURE 61	MEDBOX OVERALL FINANCIALS, 2012-2014 ($ MILLION)
FIGURE 62	SURNA INC. OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 63	CANNAGROW OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 64	ABATTIS BIOCEUTICALS OVERALL FINANCIALS 2013-14 ($MILLION)
FIGURE 65	CANNABIS THERAPY CORP. OVERALL FINANCIALS, 2014-15 ($MILLION)

REQUEST SAMPLE

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

North America Cannabis Market: Focus on Application, Derivative, and Region – Estimation & Forecast, 2015-2020

Contact Information

Contact Information

related reports

Not Found

Get yourself updated on key emerging technology markets